Alnylam Pharmaceuticals
ALNY
#661
Rank
$38.47 B
Marketcap
$288.18
Share price
0.62%
Change (1 day)
-7.97%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company